Medicago Inc., Québec City, Canada is a publicly-traded biotechnology company focused on the development, production and commercialization of protein-based biopharmaceuticals (vaccines, monoclonal antibodies, biogenerics etc) by the genetic engineering of plants. Medicago is listed on the TSX Venture Exchange under the symbol "MDG".

See also

• Plant-made pharmaceuticals

External links

• Official site
• Success story: NRC site

---

Source: Wikipedia | The above article is available under the GNU FDL. | Edit this article